268 related articles for article (PubMed ID: 19551149)
1. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Daikh DI
PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
[TBL] [Abstract][Full Text] [Related]
2. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Tang Q; Bluestone JA; Bonyhadi ML; Daikh DI
J Immunol; 2006 Aug; 177(3):1451-9. PubMed ID: 16849451
[TBL] [Abstract][Full Text] [Related]
3. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
[TBL] [Abstract][Full Text] [Related]
4. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Sharabi A; Mozes E
J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
[TBL] [Abstract][Full Text] [Related]
5. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
6. T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.
Loza MJ; Anderson AS; O'Rourke KS; Wood J; Khan IU
Cell Immunol; 2011; 271(1):110-7. PubMed ID: 21763644
[TBL] [Abstract][Full Text] [Related]
7. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
8. CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.
Weigert O; von Spee C; Undeutsch R; Kloke L; Humrich JY; Riemekasten G
Arthritis Res Ther; 2013 Feb; 15(1):R35. PubMed ID: 23446139
[TBL] [Abstract][Full Text] [Related]
9. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
10. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ T cell-dependent inhibition of autoimmunity in transgenic mice overexpressing human Bcl-2 in T lymphocytes.
González J; Tamayo E; Santiuste I; Marquina R; Buelta L; González-Gay MA; Izui S; López-Hoyos M; Merino J; Merino R
J Immunol; 2007 Mar; 178(5):2778-86. PubMed ID: 17312121
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells inhibit autoantigen-specific CD4
Rosenberger S; Undeutsch R; Akbarzadeh R; Ohmes J; Enghard P; Riemekasten G; Humrich JY
Front Immunol; 2023; 14():1254176. PubMed ID: 38022661
[TBL] [Abstract][Full Text] [Related]
15. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
16. Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
Corsini E; Oukka M; Pieters R; Kerkvliet NI; Ponce R; Germolec DR
J Immunotoxicol; 2011; 8(4):251-7. PubMed ID: 21848365
[TBL] [Abstract][Full Text] [Related]
17. Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.
Berglund D; Karlsson M; Biglarnia AR; Lorant T; Tufveson G; Korsgren O; Carlsson B
Clin Exp Immunol; 2013 Aug; 173(2):310-22. PubMed ID: 23607776
[TBL] [Abstract][Full Text] [Related]
18. Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.
Heier I; Hofgaard PO; Brandtzaeg P; Jahnsen FL; Karlsson M
Clin Exp Immunol; 2008 May; 152(2):381-7. PubMed ID: 18341610
[TBL] [Abstract][Full Text] [Related]
19. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
20. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
